Skip to Content

ENANTYUM 50 MG/2ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION

Active substance(s): DEXKETOPROFEN TROMETAMOL

View full screen / Print PDF » Download PDF ⇩
Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER
Enantyum 50 mg/2 ml
solution for injection or concentrate for solution for infusion
Dexketoprofen

Read all of this leaflet carefully before you start using this medicine because it contains important
information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
What is in this leaflet:
1.
What Enantyum is and what it is used for
2.
What you need to know before you use Enantyum
3.
How to use Enantyum
4.
Possible side effects
5.
How to store Enantyum
6.
Contents of the pack and other information

1.

What Enantyum is and what it is used for

Enantyum is a pain killer from the group of medicines called non-steroidal anti-inflammatory drugs
(NSAIDs).
It is used to treat acute moderate to severe pain, when taking tablets is not appropriate, such as postoperative pain, renal colic (severe kidney pain) and low back pain.

2.

What you need to know before you use Enantyum

Do not use Enantyum if you:













are allergic to dexketoprofen or any of the other ingredients of this medicine (listed in section 6);
are allergic to acetylsalicylic acid or to other non-steroidal anti-inflammatory medicines;
have asthma or have suffered attacks of asthma, acute allergic rhinitis (a short period of inflamed lining
of the nose), nasal polyps (lumps within the nose due to allergy), urticaria (skin rash), angioedema
(swollen face, eyes, lips, or tongue, or respiratory distress) or wheezing in the chest, after taking aspirin
or other non-steroidal anti-inflammatory medicines;
have suffered from photoallergic or phototoxic reactions (a particular form of reddening and/or
blistering of the skin exposed to sunlight) while taking ketoprofen (a non-steroidal anti-inflammatory
drug) or fibrates (drugs used to lower the level of fats in the blood);
have a peptic ulcer/ stomach or bowel bleeding or if you have suffered in the past from stomach or
bowel bleeding, ulceration or perforation;
have or have suffered in the past from stomach or bowel bleeding or perforation, due to previous use of
non-steroidal anti-inflammatory drugs (NSAIDs);
have chronic digestive problems (e.g. indigestion, heartburn);
have bowel disease with chronic inflammation (Crohn’s disease or ulcerative colitis);
have serious heart failure, moderate or serious kidney problems or serious liver problems;
have a bleeding disorder or a blood clotting disorder;

1




are severely dehydrated (have lost a lot of body fluids) due to vomiting, diarrhoea or insufficient intake
of fluids;
are in third trimester of pregnancy or breast feeding.

Warnings and precautions
Talk to your doctor before using Enantyum if you:

















have suffered in the past from a chronic inflammatory disease of the bowel (ulcerative colitis, Crohn’s
disease);
have or have suffered in the past from the other stomach or bowel problems;
are taking other medicines that increase the risk of peptic ulcer or bleeding, e.g. oral steroids, some
antidepressants (those of the SSRI type, i.e. selective serotonin reuptake inhibitors), agents that prevent
blood clots such as aspirin or anticoagulants such as warfarin. In such cases, consult your doctor before
taking Enantyum: he/she may want you to take an additional medicine to protect your stomach (e.g.
misoprostol or medicines that block the production of stomach acid);
have heart problems, previous stroke or think that you might be at risk of these conditions (for example
if you have high blood pressure, diabetes or high cholesterol or are a smoker) you should discuss your
treatment with your doctor or pharmacist; Medicines such as Enantyum may be associated with a small
increased risk of heart attack ("myocardial infarction") or stroke. Any risk is more likely with high doses
and prolonged treatment. Do not exceed the recommended dose or duration of treatment;
are elderly: you may be more likely to suffer from side effects (see section 4). If any of these occur,
consult your doctor immediately;
suffer from allergy, or if you have had allergy problems in the past;
have kidney, liver or heart problems (hypertension and/or heart failure) as well as fluid retention, or
have suffered from any of these problems in the past;
are taking diuretics or you suffer from very poor hydration and reduced blood volume due to an
excessive loss of fluids (e.g. from excessive urination, diarrhoea or vomiting);
are a woman with fertility problems (Enantyum may impair your fertility, therefore you should not use it
if you are planning to become pregnant or you are doing fertility tests);
are in the first or second trimester of pregnancy;
suffer from a disorder in the formation of blood and blood cells;
have systemic lupus erythematosus or mixed connective tissue disease (immune system disorders that
affect connective tissue);
have varicella (chickenpox), since exceptionally NSAIDs could worsen the infection;
suffer from asthma combined with chronic rhinitis, chronic sinusitis, and/or nasal polyposis as you have
a higher risk of allergy to acetylsalicylic acid and/or NSAIDs than the rest of the population.
Administration of this medicine can cause asthma attacks or bronchospasm, particularly in patients
allergic to acetylsalicylic acid or NSAIDs.

Children and adolescents
Enantyum has not been studied in children and adolescents. Therefore, safety and efficacy have not been
established and the product should not be used in children and adolescents.
Other medicines and Enantyum
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines,
including medicines obtained without a prescription. There are some medicines that should not be taken
together and others that may need their doses to be altered when taken together.
Always inform your doctor, dentist or pharmacist if you are using or receiving any of the following
medicines in addition to Enantyum:
Inadvisable combinations:

Acetylsalicylic acid (aspirin), corticosteroids or other anti-inflammatory drugs

Warfarin, heparin or other medicines used to prevent blood clots

Lithium, used to treat certain mood disorders

Methotrexate, used for rheumatoid arthritis and cancer
2



Hydantoins and phenytoin, used for epilepsy

Sulfamethoxazole, used for bacterial infections
Combinations requiring precautions:

ACE inhibitors, diuretics, beta-blockers and angiotensin II antagonists, used for high blood pressure and
heart conditions

Pentoxifylline and oxpentifylline, used to treat chronic venous ulcers

Zidovudine, used to treat viral infections

Aminoglycosides antibiotics, used to treat bacterial infections

Chlorpropamide and glibenclamide used for diabetes
Associations to be considered carefully:

Quinolone antibiotics (e.g. ciprofloxacin, levofloxacin) used for bacterial infections

Cyclosporin or tacrolimus, used to treat immune system diseases and in organ transplant

Streptokinase and other thrombolytic or fibrinolytic medicines, i.e. medicines used to break-up blood
clots

Probenecid, used in gout

Digoxin, used to treat chronic heart failure

Mifepristone, used as an abortifacient (to terminate a pregnancy)

Antidepressants of the selective serotonin reuptake inhibitors type (SSRIs)

Anti-platelet agents used to reduce platelet aggregation and the formation of blood clots
If you have any doubt about taking other medicines with Enantyum, consult your doctor or pharmacist.
Pregnancy, breast-feeding and fertility
Do not use Enantyum during the final three months of the pregnancy or when breast feeding. Ask your doctor
for advice.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist
for advice before taking this medicine, as Enantyum may not be right for you.
Use of Enantyum should be avoided by women who are planning a pregnancy or are pregnant. Treatment at
any time in pregnancy should only take place as directed by a doctor.
The use of Enantyum is not recommended while attempting to conceive or during investigation of infertility.
Driving and using machines
Enantyum may slightly affect your ability to drive and handle machines, due to the possibility of dizziness
or drowsiness as side effects of treatment. If you notice such effects, do not drive or use machines until the
symptoms wear off. Ask your doctor for advice.
Enantyum contains ethanol
Each ampoule of Enantyum contains 200mg of ethanol, equivalent to 5 ml beer or 2.08 ml wine per dose.
Harmful for those suffering from alcoholism.
To be taken into account in pregnant or breast-feeding women, children and high-risk groups such as
patients with liver disease, or epilepsy.
This medicinal product contains less than 1 mmol sodium (23mg) per dose, i.e. essentially “sodium-free”.

3.

How to use Enantyum

Always use this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Your doctor will tell you what is the dose of Enantyum that you need, according to the type, severity and
duration of your symptoms. The recommended dose is generally 1 ampoule (50 mg) of Enantyum every 8 12 hours. If needed, the injection can be repeated after only 6 hours. Do not exceed a total daily dose of 150
mg of Enantyum (3 ampoules) in any case.
Use the injection treatment only in the acute period (i.e. no longer than two days). Switch to an oral pain
killer when possible.
The elderly with renal dysfunction and patients with kidney or liver problems should not exceed a total daily
dose of 50 mg of Enantyum (1 ampoule).

3

Method of administration:
Enantyum can be administered either by intramuscular or by intravenous route (technical details for the
intravenous injection are given in the section 7).
When Enantyum is given intramuscularly, the solution should be injected immediately after its removal from
the coloured ampoule, by slow injection deep into the muscle.
Only a clear and colourless solution should be used.
Use in children and adolescents
This medicine should not be used in children and adolescents (under age 18).
If you use more Enantyum than you should
If you use too much of this medicine, tell your doctor or pharmacist immediately or go to the emergency
department of your nearest hospital. Please remember to take this medicine pack or this leaflet with you.
If you forget to use Enantyum
Do not use a double dose to make up for a forgotten dose. Use the next regular dose when it is due
(according to section 3 “How to use Enantyum”).
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible side effects are listed below according to how likely they are to occur.
Common side effects: may affect up to 1 in 10 people
Nausea and/or vomiting, injection site pain, injection site reactions, e.g. inflammation, bruising or
haemorrhage.
Uncommon side effects: may affect up to 1 in 100 people
Vomiting blood, low blood pressure, fever, blurred vision, dizziness, sleepiness, sleep disturbances,
headache, anaemia, abdominal pain, constipation, digestive problems, diarrhoea, dry mouth, flushing, rash,
dermatitis, itching, sweating increased, tiredness, pain, feeling cold.
Rare side effects: may affect up to 1 in 1,000 people
Peptic ulcer, peptic ulcer haemorrhage or peptic ulcer perforation, high blood pressure, fainting, too-slow
breathing, inflammation of a superficial vein due to a blood clot (superficial thrombophlebitis), isolated
heart skip (extrasystole), fast heartbeat, peripheral oedema, laryngeal oedema, abnormal sensation, feeling
feverish and shivering, ringing in the ears (tinnitus), itchy rash, jaundice, acne, back pain, renal pain, passing
water frequently, menstrual disorders, prostate problems, muscle stiffness, joint stiffness, muscle cramp,
abnormal liver tests (blood tests), increased blood sugar level (hyperglyceaemia), decreased blood sugar
level (hypoglyceaemia), increased triglyceride fats concentration in blood (hypertriglyceridaemia), ketone
bodies in the urine (ketonuria), proteins in the urine (proteinuria), liver cell injury (hepatitis), acute renal
failure.
Very rare: may affect up to 1 in 10,000 people
Anaphylactic reaction (hypersensitive reaction which may also lead to a collapse), ulceration of the skin,
mouth, eyes and genital areas (Stevens Johnson and Lyell’s syndromes), facial swelling or swelling of the
lips and throat (angioedema), breathlessness due to contraction of the muscles around the airways
(bronchospasm), shortness of breath, pancreatitis, skin sensitivity reactions and skin over-sensitivity to light,
renal damage, reduced white blood cell count (neutropenia), reduced platelet count (thrombocytopenia).
Tell your doctor immediately if you notice any stomach/bowel side effects at the start of treatment (e.g.
stomach pain, heartburn or bleeding), if you have previously suffered from any such side effects due to longterm use of anti-inflammatory drugs, and especially if you are elderly.
4

Stop using Enantyum as soon as you notice the appearance of a skin rash, or any lesion on the mucous
surfaces (e.g. the surface along the inside of the mouth), or any sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, fluid retention and swelling (especially in the
ankles and legs), a raise in blood pressure and heart failure have been reported.
Medicines such as Enantyum may be associated with a small increased risk of heart attack ("myocardial
infarction") or stroke.
In patients with systemic lupus erythematosus or mixed connective tissue disease (immune system disorders
that affect connective tissue), anti-inflammatory medicines may rarely cause fever, headache and stiffness of
the back of the neck.
Tell your doctor immediately if signs of infection occur or get worse whilst using Enantyum.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme. Website:
www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the
safety of this medicine.
5.

How to store Enantyum

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the ampoule. The expiry
date refers to the last day of that month.
Keep the ampoule in the outer carton in order to protect it from light.
Do not use this medicine if you notice that the solution is not clear and colourless, but shows signs of
deterioration (e.g. particles). Enantyum solution for injection or concentrate for solution for infusion is for
single use only and should be used immediately once opened. Discard any unused quantity of the product
(please see “disposal” subsection below).
Disposal
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use and how to properly dispose of your used needles and syringes. These
measures will help to protect the environment.

6.

Contents of the pack and other information

What each 2 ml ampoule of ENANTYUM contains
The active substance is dexketoprofen trometamol (73,80 mg) corresponding to dexketoprofen (INN) 50 mg.
The other ingredients are alcohol (ethanol), sodium chloride, sodium hydroxide and water for injections.
What ENANTYUM looks like and contents of the pack
Enantyum is a solution for injection or a concentrate for solution for infusion. It is supplied in packs
containing 1, 5, 6, 10, 20, 50 and 100 type I glass coloured ampoules each one with 2 ml of a clear and
colourless solution. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
5

Marketing Authorisation Holder:
LABORATORIOS MENARINI S.A.
C/Alfonso X11, 587
08918 Badalona- Barcelona
Spain
Manufacturer:
A MENARINI MANUFACTURING LOGISTICS AND SERVICES S.R.L.
Via Sette Santi 3,
50131 Firenze,
ITALY
or
Alfa Wassermann S.p.A.,
via Enrico Fermi, 1
65020 Alanno (Pescara)
Italy

This medicinal product is authorised in the Member States of the EEA under the following names:
Spain (RMS)

Enantyum

Latvia

Ketesse

Austria

Enantyum

Lithuania

Ketesse

Belgium

Enantyum

Luxembourg

Enantyum

Czech republic

Ketesse

Norway

Orodek

Denmark

Enantyum

Poland

Ketesse

Estonia

Ketesse

Portugal

Enantyum

Greece

Viaxal

Slovakia

Ketesse

Hungary

Enantyum

Slovenia

Ketesse

Iceland

Enantyum

Sweden

Enantyum

Ireland

Enantyum

The Netherlands

Enantyum

Italy

Enantyum

United Kingdom

Enantyum

This leaflet was last revised in 04/2015.

6

7. INFORMATION FOR THE HEALTH PROFESSIONAL
The following information is intended for healthcare professionals only:
Intravenous use:
Intravenous infusion: the contents of one ampoule (2 ml) of Enantyum should be diluted in a
volume of 30 to 100 ml of Normal Saline, 5% glucose or ringer lactate solution. The diluted
solution should be given as a slow intravenous infusion, lasting 10 to 30 min. The solution must
be always protected from natural daylight.
Intravenous bolus: if necessary, the content of one ampoule (2 ml) Enantyum can be given in
a slow intravenous bolus over no less than 15 seconds.
Enantyum is contraindicated for neuraxial (intrathecal or epidural) administration due to
its ethanol content.
Instructions on handling the product:
When Enantyum is given as intravenous bolus the solution should be injected immediately after
its removal from the coloured ampoule.
For administration as intravenous infusion, the solution should be diluted aseptically and
protected from natural daylight.
Only a clear and colourless solution should be used.
Compatibilities:
Enantyum has shown to be compatible when mixed in small volumes (e.g. in a syringe) with
injectable solutions of heparin, lidocaine, morphine and theophylline.
The solution for injection diluted as indicated is a clear solution. Enantyum diluted in a volume
of 100 ml of normal saline or glucose solution has been shown to be compatible with the
following solutions for injection: dopamine, heparin, hydroxyzine, lidocaine, morphine,
pethidine and theophylline.
No absorption of the active ingredient has been found when diluted solutions of Enantyum have
been stored in plastic bags or administration devices made of Ethyl Vinyl Acetate (EVA),
Cellulose Propionate (CP), Low Density Polyethylene (LDPE) and Polyvinyl Chloride (PVC).

7

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide